Return to homepagePandemic Pact

THE RISK OF COVID-19 IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $64,425

  • Funder

    Lundbeck Foundation

  • Principal Investigator

    N/A

  • Research Location

    Denmark

  • Lead Research Institution

    Statens Serum Institut

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

A range of disorders such as rheumatoid arthritis, psoriasis, colitis and Crone's disease develop when the immune system overreacts and begins to attack the body. It is unknown whether patients suffering from such diseases are particularly at risk of becoming seriously ill if they are given Covid19. A team of researchers at the Danish serum institute, SSI, will therefore investigate their risk and the impact of the medicine they are already taking on the course of COVID-19 in these patients.